Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX8TNH
|
||||
Drug Name |
4-(3,4-Difluoro-phenyl)-5-methyl-2-oxo-oxazolidine-3-carboxylic acid {3-[4-(4-fluoro-phenyl)-piperidin-1-yl]-propyl}-amide
|
||||
Synonyms |
CHEMBL2111563
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H28F3N3O3
|
||||
Canonical SMILES |
C[C@H]1OC(=O)N([C@@H]1c2ccc(F)c(F)c2)C(=O)NCCCN3CCC(CC3)c4ccc(F)cc4
|
||||
InChI |
InChI=1S/C25H28F3N3O3/c1-16-23(19-5-8-21(27)22(28)15-19)31(25(33)34-16)24(32)29-11-2-12-30-13-9-18(10-14-30)17-3-6-20(26)7-4-17/h3-8,15-16,18,23H,2,9-14H2,1H3,(H,29,32)/t16-,23+/m1/s1
|
||||
InChIKey |
DTYAFBJXWWLRMA-MWTRTKDXSA-N
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
Histamine H1 receptor | Target Info | [1587926] | |||
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.